Retraction Note to: Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study

被引：0
|
作者：
Qing Zhu
Tongtao Liu
机构：
[1] Qilu Hospital,Department of Cardiology
[2] Shandong University,undefined
来源：
Molecular Biology Reports | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：751 / 751
相关论文
共 50 条
  • [21] Fibroblast Growth Factor 23 and Mortality in Patients With Suspected or Known Coronary Artery Disease: From the ANOX Study
    Wada, Hiromichi
    Kotani, Kazuhiko
    Suzuki, Masahiro
    Matsuda, Morihiro
    Ajiro, Yoichi
    Shinozaki, Tsuyoshi
    Sakagami, Satoru
    Yonezawa, Kazuya
    Shimizu, Masatoshi
    Funada, Junichi
    Takenaka, Takashi
    Morita, Yukiko
    Nakamura, Toshihiro
    Fujimoto, Kazuteru
    Matsubara, Hiromi
    Kato, Toru
    Unoki, Takashi
    Takagi, Daisuke
    Wada, Kyohma
    Wada, Miyaka
    Iguchi, Moritake
    Masunaga, Nobutoyo
    Ishii, Mitsuru
    Abe, Mitsuru
    Akao, Masaharu
    Hasegawa, Koji
    CIRCULATION, 2019, 140
  • [22] Association of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Gene Polymorphisms with Coronary Artery Lesions of Kawasaki Disease
    Hidehiko Kariyazono
    Takuro Ohno
    Vahid Khajoee
    Kenji Ihara
    Koichi Kusuhara
    Naoko Kinukawa
    Yumi Mizuno
    Toshiro Hara
    Pediatric Research, 2004, 56 : 953 - 959
  • [23] Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease
    Kariyazono, H
    Ohno, T
    Khajoee, V
    Ihara, K
    Kusuhara, K
    Kinukawa, N
    Mizuno, Y
    Hara, T
    PEDIATRIC RESEARCH, 2004, 56 (06) : 953 - 959
  • [24] Association of polymorphisms in the MAFB gene and the risk of coronary artery disease and ischemic stroke: a case–control study
    Qian Yang
    Rui-Xing Yin
    Yi-Jiang Zhou
    Xiao-Li Cao
    Tao Guo
    Wu-Xian Chen
    Lipids in Health and Disease, 14
  • [25] The role of fibroblast growth factor receptor 4 polymorphisms in the susceptibility and clinical features of ischemic stroke
    Yin, Changhao
    Li, Siou
    Zhao, Weina
    Guo, Yanqin
    Zhang, Ying
    Feng, Jiachun
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (02) : 246 - 249
  • [26] Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
    Shen, Yun
    Ma, Xiaojing
    Zhou, Jian
    Pan, Xiaoping
    Hao, Yaping
    Zhou, Mi
    Lu, Zhigang
    Gao, Meifang
    Bao, Yuqian
    Jia, Weiping
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [27] Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
    Yun Shen
    Xiaojing Ma
    Jian Zhou
    Xiaoping Pan
    Yaping Hao
    Mi Zhou
    Zhigang Lu
    Meifang Gao
    Yuqian Bao
    Weiping Jia
    Cardiovascular Diabetology, 12
  • [28] Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels
    Hu, Xiang
    Ma, Xiaojing
    Pan, Xiaoping
    Hao, Yaping
    Luo, Yuqi
    Lu, Zhigang
    Bao, Yuqian
    Jia, Weiping
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (11): : 1152 - 1157
  • [29] Additive Relationship between Serum Fibroblast Growth Factor 21 Level and Coronary Artery Disease
    Shen, Yun
    Ma, Xiaojing
    Zhou, Jian
    Pan, Xiaoping
    Hao, Yaping
    Zhou, Mi
    Bao, Yuqian
    Jia, Weiping
    DIABETES, 2014, 63 : A115 - A115
  • [30] Decreased levels of serum fibroblast growth factor 21 in Chinese patients with coronary artery disease
    Chen, Hai-Feng
    Wu, Feng
    Lu, Nan
    Zheng, Wei-Ping
    Lin, Kai-Yang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9625 - 9630
12345